Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
3 CALLS ON FILE
BCAX
— Bicara Therapeutics Inc. Common Stock
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 11, 2026
REVENUE
$0
EPS
-$0.82
+11.8%
FREE CASH FLOW
-$44.3M
-17.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 3
OLDER CALL →